Risk of Psychosis Among Refugees: A Systematic Review and Meta-analysis.


Journal

JAMA psychiatry
ISSN: 2168-6238
Titre abrégé: JAMA Psychiatry
Pays: United States
ID NLM: 101589550

Informations de publication

Date de publication:
01 11 2019
Historique:
pubmed: 15 8 2019
medline: 14 1 2021
entrez: 15 8 2019
Statut: ppublish

Résumé

This systematic review and meta-analysis is, to date, the first and most comprehensive to focus on the incidence of nonaffective psychoses among refugees. To assess the relative risk (RR) of incidence of nonaffective psychosis in refugees compared with the RR in the native population and nonrefugee migrants. PubMed, PsycINFO, and Embase databases were searched for studies from January 1, 1977, to March 8, 2018, with no language restrictions (PROSPERO registration No. CRD42018106740). Studies conducted in Denmark, Sweden, Norway, and Canada were selected by multiple independent reviewers. Inclusion criteria were (1) observation of refugee history in participants, (2) assessment of effect size and spread, (3) adjustment for sex, (4) definition of nonaffective psychosis according to standardized operationalized criteria, and (5) comparators were either nonrefugee migrants or the native population. Studies observing ethnic background only, with no explicit definition of refugee status, were excluded. The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) and the Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines were followed for extracting data and assessing data quality and validity as well as risk of bias of included studies. A random-effects model was created to pool the effect sizes of included studies. The primary outcome, formulated before data collection, was the pooled RR in refugees compared with the nonrefugee population. Of the 4358 screened articles, 9 studies (0.2%) involving 540 000 refugees in Denmark, Sweden, Norway, and Canada were included in the analyses. The RR for nonaffective psychoses in refugees was 1.43 (95% CI, 1.00-2.05; I2 = 96.3%) compared with nonrefugee migrants. Analyses that were restricted to studies with low risk of bias had an RR of 1.39 (95% CI, 1.23-1.58; I2 = 0.0%) for refugees compared with nonrefugee migrants, 2.41 (95% CI, 1.51-3.85; I2 = 96.3%) for refugees compared with the native population, and 1.92 (95% CI, 1.02-3.62; I2 = 97.0%) for nonrefugee migrants compared with the native group. Exclusion of studies that defined refugee status not individually but only by country of origin resulted in an RR of 2.24 (95% CI, 1.12-4.49; I2 = 96.8%) for refugees compared with nonrefugee migrants and an RR of 3.26 (95% CI, 1.87-5.70; I2 = 97.6%) for refugees compared with the native group. In general, the RR of nonaffective psychosis was increased in refugees and nonrefugee migrants compared with the native population. Refugee experience appeared to be an independent risk factor in developing nonaffective psychosis among refugees in Denmark, Sweden, Norway, and Canada. These findings suggest that applying the conclusions to non-Scandinavian countries should include a consideration of the characteristics of the native society and its specific interaction with the refugee population.

Identifiants

pubmed: 31411649
pii: 2747572
doi: 10.1001/jamapsychiatry.2019.1937
pmc: PMC6694397
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1133-1140

Commentaires et corrections

Type : CommentIn

Références

Eur Arch Psychiatry Clin Neurosci. 1994;244(3):126-30
pubmed: 7803525
Soc Psychiatry Psychiatr Epidemiol. 2003 Sep;38(9):515-9
pubmed: 14504736
Am J Psychiatry. 2005 Jan;162(1):12-24
pubmed: 15625195
Psychother Psychosom Med Psychol. 2015 Sep;65(9-10):353-62
pubmed: 26039370
Soc Sci Med. 1995 Mar;40(6):777-87
pubmed: 7747212
J Clin Epidemiol. 2012 Sep;65(9):934-9
pubmed: 22742910
Eur Psychiatry. 2012 Jun;27 Suppl 2:S50-5
pubmed: 22863251
Br J Psychiatry. 2004 May;184:428-31
pubmed: 15123507
Epidemiol Psichiatr Soc. 2009 Jan-Mar;18(1):23-33
pubmed: 19378696
Br J Psychiatry. 2004 Apr;184:293-8
pubmed: 15056572
Lancet. 2005 Apr 9-15;365(9467):1309-14
pubmed: 15823380
Acta Psychiatr Scand. 2004 Jan;109(1):38-45
pubmed: 14674957
Acta Psychiatr Scand Suppl. 2000;(407):38-43
pubmed: 11261638
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
Schizophr Bull. 2012 Jun;38(4):661-71
pubmed: 22461484
BMJ. 2016 Mar 15;352:i1030
pubmed: 26979256
J Nerv Ment Dis. 2006 Jan;194(1):27-33
pubmed: 16462552
Eur Psychiatry. 2012 Jun;27 Suppl 2:S44-9
pubmed: 22863250
Int J Epidemiol. 2007 Jun;36(3):666-76
pubmed: 17470488
Eur Psychiatry. 2008 Jan;23 Suppl 1:21-7
pubmed: 18371576
Int J Soc Psychiatry. 2010 Jan;56(1):74-93
pubmed: 19592449
Schizophr Bull. 2019 Sep 11;45(5):1092-1100
pubmed: 30388260
Transl Psychiatry. 2017 Jun 13;7(6):e1149
pubmed: 28608852
Psychol Med. 1986 Nov;16(4):909-28
pubmed: 3493497
J Chronic Dis. 1983;36(10):715-23
pubmed: 6630407
Eur Psychiatry. 2012 Jun;27 Suppl 2:S56-62
pubmed: 22863252
Am J Public Health. 2013 Mar;103(3):e30-42
pubmed: 23327250
CMAJ. 2015 Jun 16;187(9):E279-E286
pubmed: 25964387
Nervenarzt. 2008 Mar;79(3):328-39
pubmed: 18210042
World Psychiatry. 2015 Jun;14(2):249-50
pubmed: 26043348
Eur Arch Psychiatry Clin Neurosci. 2020 Apr;270(3):325-335
pubmed: 31161262
Eur J Public Health. 2014 Aug;24 Suppl 1:72-9
pubmed: 25108001
JAMA Psychiatry. 2015 Jul;72(7):697-705
pubmed: 26018466
J Nerv Ment Dis. 2018 Jan;206(1):3-10
pubmed: 27483113
Psychol Med. 2011 May;41(5):897-910
pubmed: 20663257
Clin Psychol Rev. 2016 Nov;49:92-105
pubmed: 27632064
Ethn Health. 2005 Aug;10(3):243-56
pubmed: 16087456
Transcult Psychiatry. 2006 Dec;43(4):577-91
pubmed: 17166947
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016 May;59(5):621-6
pubmed: 27072498
Soc Psychiatry Psychiatr Epidemiol. 2009 Dec;44(12):1023-9
pubmed: 19294322
BJPsych Open. 2016 Jan 13;2(1):6-9
pubmed: 27703747
Eur J Psychotraumatol. 2015 Sep 01;6:26286
pubmed: 26333540
Br J Psychiatry. 2009 Apr;194(4):306-12
pubmed: 19336779
Psychol Med. 2018 Feb 22;:1-15
pubmed: 29467052
Eur J Public Health. 2013 Apr;23(2):279-84
pubmed: 22577125

Auteurs

Lasse Brandt (L)

Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Jonathan Henssler (J)

Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Martin Müller (M)

Department of Emergency Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Institute of Health Economics and Clinical Epidemiology, University Hospital of Cologne, Cologne, Germany.

Stephanie Wall (S)

Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin, Berlin, Germany.

David Gabel (D)

Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin, Berlin, Germany.

Andreas Heinz (A)

Department of Psychiatry and Psychotherapy, Campus Charité Mitte, Charité-Universitätsmedizin Berlin, Berlin, Germany.
Berlin School of Mind and Brain, Berlin, Germany.
Bernstein Center of Computational Neuroscience, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH